|
|
Article: BTG Announces Licensing and Research Agreement with the University of Illinois at Chicago to Develop Novel Therapy for Treatment of Sleep Apnea.
- Article from:
- Business Wire
- Article date:
- September 28, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WEST CONSHOHOCKEN, Pa. -- Innovative pharmacological approach for the treatment of sleep-related breathing disorder
BTG (LSE: BGC), the intellectual property and technology commercialization company, today announced that it has signed a licensing and research agreement with the University of Illinois at Chicago (UIC) to further develop a novel pharmacological therapy for the treatment of sleep apnea. BTG plans to invest in the development of this innovative therapy to expand its portfolio of therapeutic programs, particularly in the area of drug repositioning. Under the terms of the agreement, UIC grants BTG specific exclusive rights to intellectual property and ...